The global compounding pharmacy market size is estimated to be USD xx billion and is expected to witness a CAGR of xx% during the forecast period. Rise in global geriatric population and better life expectancy is a key driver for the growth of the global compounding pharmacy market. Additionally, growth in adoption of modified medicine in the developed economies and scarcity of drugs across the globe in the compounding pharmacy market are some of the other drivers propelling the market growth. Nevertheless, shortage of skilled pharmacists and lab technicians in the developing economies and high cost of equipment and upkeep of disinfected environment are expected to restrain the global market growth.
Global Compounding Pharmacy Market Size (USD Billion), 2021-2029
Source: Erevna Healthcare
By Product
Based on product, the market is segmented into topical medications, oral medications, suppositories, and others. In the oral medications segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to the increase in application of this form of medications such as capsules and tablets for various ailments worldwide. Topical medications segment projected to grow at a profitable CAGR during the forecast period. This is attributed to the increase in market for hormone replacement therapies and the rise in demand from the dermatological applications.
By Therapeutic Area
Based on therapeutic area, the market is segmented into hormone replacement medications, pain medications, dermatological applications, and others. In the pain medications segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to the growth in prevalence of chronic pain amongst adults this is due to deskbound lifestyle or trauma owing to accidents worldwide. Hormone replacement medications segment projected to grow at a profitable CAGR during the forecast period. This is attributed to the increase in number of patients showing positive acceptance for hormone replacement therapy medications.
Regional Insights
In North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the increase in demand for custom-made dosages, inventive therapeutic areas, increase in the share of healthcare expenditure in the per capita income, growth in initiatives from government in the region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the accessibility of technological advanced products, growing government and corporate investment in healthcare sector, increasing travel tourism in the developing economies, and availability of raw material used for manufacturing these medications at economic costs, are the major factors in this region.
Competitor Insights
Some of the key players in the compounding pharmacy market are F Fagron, Inc. (U.S.); Triangle Compounding Pharmacy (U.S.); B.Braun Melsungen AG (Germany); PharMEDium Healthcare Holdings, Inc. (U.S.); Fresenius Kabi AG (Germany); Avella Specialty Pharmacy (U.S.); Vertisis Custom Pharmacy (U.S.); US Compounding Inc. (U.S.); Belle Santé Diagnostic & Therapeutic Institute Pvt. Ltd. (India); and Elixir Compounding Pharmacy (Australia). The leading players operating in the compounding pharmacy industry are adopting various strategies including R&D investments, adaption of advanced techniques, new technology launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.
This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The compounding pharmacy market report is categorized into the following segments and subsegments:
Compounding Pharmacy Market, By Product (Revenue, USD Billion, 2021 – 2029)
- Topical Medications
- Oral Medications
- Suppositories
- Others
Compounding Pharmacy Market, By Therapeutic Area (Revenue, USD Billion, 2021 – 2029)
- Hormone Replacement Medications
- Pain Medications
- Dermatological Applications
- Others
Compounding Pharmacy Market, By Region (Revenue, USD Billion, 2021 – 2029)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- Saudi Arabia
- Rest of MEA
Scope of Compounding Pharmacy Market Report:
Key Parameters | Details |
---|---|
Base Year |
|
Forecast Period |
|
Study Coverage |
|
Qualitative Analysis |
|
Regional Market Scope |
|
Company Profiles |
|
15% Free Customization Available |
|
Table of Contents: Compounding Pharmacy Market 2021-2029
- Research Methodology
- Study Objectives
- Study Scope
- Research Assumptions
- Research Framework
- Research Models
- Bottom-up Approach
- Top-down Approach
- Data Triangulation
- Data Procurement
- Internal Database
- Secondary Research
- Purchased Database
- Primary Research
- Data Analysis
- Data Validation
- Market Size Estimation
- Market Forecast Model
- Quality Assessment
- Research Models
- Introduction: Compounding Pharmacy
- Executive Summary
- Global Market Scenario
- Segment Market Scenario
- Geographic Market Scenario
- COVID-19 Impact
- Competitive Landscape
- Market Dynamics
- Market Drivers
- Driver 1
- Driver 2
- Driver 3
- Driver 4
- Driver 5
- Market Restraint
- Restraint 1
- Restraint 2
- Restraint 3
- Restraint 4
- Market Opportunities
- Opportunity 1
- Opportunity 2
- Opportunity 3
- Opportunity 4
- Market Trends
- Trend 1
- Trend 2
- Trend 3
- Trend 4
- Market Challenges
- Challenge 1
- Challenge 2
- Challenge 3
- Challenge 4
- Market Drivers
- Market Environment Analysis
- Porter’s 5 Forces Analysis
- PESTEL Analysis
- Value Chain Analysis
- SWOT Analysis
- Benchmark
- COVID-19 Impact Analysis: Compounding Pharmacy Market
- COVID-19: Overview
- COVID-19 Impact on the Global Market
- COVID-19 Impact on the Regional Markets
- Market Analysis by Product
- Topical Medications
- Topical Medications Market Forecast, 2021-2029 (USD Million)
- Oral Medications
- Oral Medications Market Forecast, 2021-2029 (USD Million)
- Suppositories
- Suppositories Market Forecast, 2021-2029 (USD Million)
- Others
- Others Market Forecast, 2021-2029 (USD Million)
- Topical Medications
- Market Analysis by Therapeutic Area
- Hormone Replacement Medications
- Hormone Replacement Medications Market Forecast, 2021-2029 (USD Million)
- Pain Medications
- Pain Medications Market Forecast, 2021-2029 (USD Million)
- Dermatological Applications
- Dermatological Applications Market Forecast, 2021-2029 (USD Million)
- Others
- Others Market Forecast, 2021-2029 (USD Million)
- Hormone Replacement Medications
- Regional Market Analysis
- Regional Market Trends
- Regional Market: Comparative Analysis
- North America Compounding Pharmacy Market
- North America Compounding Pharmacy Market
- North America Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Product, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
- S. Compounding Pharmacy Market
- S. Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Product, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
- Canada Compounding Pharmacy Market
- Canada Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Product, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
- Canada Market Size and Forecast, 2021-2029 (USD Million)
- S. Market Size and Forecast, 2021-2029 (USD Million)
- North America Market Size and Forecast, 2021-2029 (USD Million)
- North America Compounding Pharmacy Market
- Europe Compounding Pharmacy Market
- Europe Compounding Pharmacy Market
- Europe Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Product, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
- Germany Compounding Pharmacy Market
- Germany Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Product, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
- UK Compounding Pharmacy Market
- UK Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Product, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
- France Compounding Pharmacy Market
- France Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Product, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
- Spain Compounding Pharmacy Market
- Spain Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Product, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
- Italy Compounding Pharmacy Market
- Italy Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Product, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
- Rest of Europe Compounding Pharmacy Market
- Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Product, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
- Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
- Italy Market Size and Forecast, 2021-2029 (USD Million)
- Spain Market Size and Forecast, 2021-2029 (USD Million)
- France Market Size and Forecast, 2021-2029 (USD Million)
- UK Market Size and Forecast, 2021-2029 (USD Million)
- Germany Market Size and Forecast, 2021-2029 (USD Million)
- Europe Market Size and Forecast, 2021-2029 (USD Million)
- Europe Compounding Pharmacy Market
- Asia Pacific Compounding Pharmacy Market
- Asia Pacific Compounding Pharmacy Market
- Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Product, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
- Japan Compounding Pharmacy Market
- Japan Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Product, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
- China Compounding Pharmacy Market
- China Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Product, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
- India Compounding Pharmacy Market
- India Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Product, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
- South Korea Compounding Pharmacy Market
- South Korea Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Product, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
- Market Size and Forecast by Device, 2021-2029 (USD Million)
- Australia Compounding Pharmacy Market
- Australia Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Product, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
- Rest of Asia Pacific Compounding Pharmacy Market
- Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Product, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
- Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
- Australia Market Size and Forecast, 2021-2029 (USD Million)
- South Korea Market Size and Forecast, 2021-2029 (USD Million)
- India Market Size and Forecast, 2021-2029 (USD Million)
- China Market Size and Forecast, 2021-2029 (USD Million)
- Japan Market Size and Forecast, 2021-2029 (USD Million)
- Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
- Asia Pacific Compounding Pharmacy Market
- Latin America Compounding Pharmacy Market
- Latin America Compounding Pharmacy Market
- Latin America Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Product, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
- Brazil Compounding Pharmacy Market
- Brazil Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Product, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
- Mexico Compounding Pharmacy Market
- Mexico Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Product, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
- Argentina Compounding Pharmacy Market
- Argentina Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Product, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
- Rest of Latin America Compounding Pharmacy Market
- Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Product, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
- Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
- Argentina Market Size and Forecast, 2021-2029 (USD Million)
- Mexico Market Size and Forecast, 2021-2029 (USD Million)
- Brazil Market Size and Forecast, 2021-2029 (USD Million)
- Latin America Market Size and Forecast, 2021-2029 (USD Million)
- Latin America Compounding Pharmacy Market
- MEA Compounding Pharmacy Market
- MEA Compounding Pharmacy Market
- MEA Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Product, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
- GCC Compounding Pharmacy Market
- GCC Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Product, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
- South Africa Compounding Pharmacy Market
- South Africa Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Product, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
- Rest of MEA Compounding Pharmacy Market
- Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Product, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Area, 2021-2029 (USD Million)
- Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
- South Africa Market Size and Forecast, 2021-2029 (USD Million)
- GCC Market Size and Forecast, 2021-2029 (USD Million)
- MEA Market Size and Forecast, 2021-2029 (USD Million)
- MEA Compounding Pharmacy Market
- Competitor Analysis
- Market Share Analysis, 2021 & 2029
- Competitive Mapping
- Key Players Market Place Analysis
- Major Recent Developments
- Company Profiles
- F Fagron, Inc. (U.S.)
- Company Snapshot
- Company Overview
- Financials
- Product Benchmarking
- Recent Developments
- Triangle Compounding Pharmacy (U.S.)
- Company Snapshot
- Company Overview
- Financials
- Product Benchmarking
- Recent Developments
- Braun Melsungen AG (Germany)
- Company Snapshot
- Company Overview
- Financials
- Product Benchmarking
- Recent Developments
- PharMEDium Healthcare Holdings, Inc. (U.S.)
- Company Snapshot
- Company Overview
- Financials
- Product Benchmarking
- Recent Developments
- Fresenius Kabi AG (Germany)
- Company Snapshot
- Company Overview
- Financials
- Product Benchmarking
- Recent Developments
- Avella Specialty Pharmacy (U.S.)
- Company Snapshot
- Company Overview
- Financials
- Product Benchmarking
- Recent Developments
- Vertisis Custom Pharmacy (U.S.)
- Company Snapshot
- Company Overview
- Financials
- Product Benchmarking
- Recent Developments
- US Compounding Inc. (U.S.)
- Company Snapshot
- Company Overview
- Financials
- Product Benchmarking
- Recent Developments
- Belle Santé Diagnostic & Therapeutic Institute Pvt. Ltd. (India)
- Company Snapshot
- Company Overview
- Financials
- Product Benchmarking
- Recent Developments
- Elixir Compounding Pharmacy (Australia)
- Company Snapshot
- Company Overview
- Financials
- Product Benchmarking
- Recent Developments
- Company 11
- Company Snapshot
- Company Overview
- Financials
- Product Benchmarking
- Recent Developments
- Company 12
- Company Snapshot
- Company Overview
- Financials
- Product Benchmarking
- Recent Developments
- Company 13
- Company Snapshot
- Company Overview
- Financials
- Product Benchmarking
- Recent Developments
- Company 14
- Company Snapshot
- Company Overview
- Financials
- Product Benchmarking
- Recent Developments
- Company15
- Company Snapshot
- Company Overview
- Financials
- Product Benchmarking
- Recent Developments
- Others Prominent Players
- F Fagron, Inc. (U.S.)
Conclusion & Recommendations